These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12594105)

  • 1. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel.
    van Tubergen A; van der Heijde D; Anderson J; Landewé R; Dougados M; Braun J; Bellamy N; Udrea G; van der Linden S
    Ann Rheum Dis; 2003 Mar; 62(3):215-21. PubMed ID: 12594105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics.
    Stone MA; Inman RD; Wright JG; Maetzel A
    Arthritis Rheum; 2004 Jun; 51(3):316-20. PubMed ID: 15188313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experts' beliefs on physiotherapy for patients with ankylosing spondylitis and assessment of their knowledge on published evidence in the field. Results of a questionnaire among international ASAS members.
    Mihai B; van der Linden S; de Bie R; Stucki G
    Eura Medicophys; 2005 Jun; 41(2):149-53. PubMed ID: 16200031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
    Braun J; Davis J; Dougados M; Sieper J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2006 Mar; 65(3):316-20. PubMed ID: 16096329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.
    Braun J; Pham T; Sieper J; Davis J; van der Linden S; Dougados M; van der Heijde D;
    Ann Rheum Dis; 2003 Sep; 62(9):817-24. PubMed ID: 12922952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
    Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.
    Anderson JJ; Baron G; van der Heijde D; Felson DT; Dougados M
    Arthritis Rheum; 2001 Aug; 44(8):1876-86. PubMed ID: 11508441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].
    Braun J; Zochling J; Märker-Hermann E; Stucki G; Böhm H; Rudwaleit M; Zeidler H; Sieper J
    Z Rheumatol; 2006 Dec; 65(8):728-42. PubMed ID: 17119900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicenter, double-blind, placebo-controlled, randomized, phase III clinical study of etanercept in treatment of ankylosing spondylitis].
    Huang F; Zhang J; Huang JL; Wu DH; Li ZG; Chen SL; Pan YF; Ma L; Chen S; Lü LJ; Yang ZM
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):741-5. PubMed ID: 21092442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S133-41. PubMed ID: 16273797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group.
    Pham T; van der Heijde D; Calin A; Khan MA; van der Linden S; Bellamy N; Dougados M;
    Ann Rheum Dis; 2003 Sep; 62(9):812-6. PubMed ID: 12922951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
    Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
    Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial.
    Haibel H; Brandt HC; Song IH; Brandt A; Listing J; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2007 Mar; 66(3):419-21. PubMed ID: 16901959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ASAS-OMERACT core domain set for axial spondyloarthritis.
    Navarro-Compán V; Boel A; Boonen A; Mease P; Landewé R; Kiltz U; Dougados M; Baraliakos X; Bautista-Molano W; Carlier H; Chiowchanwisawakit P; Dagfinrud H; de Peyrecave N; El-Zorkany B; Fallon L; Gaffney K; Garrido-Cumbrera M; Gensler LS; Haroon N; Kwan YH; Machado PM; Maksymowych WP; Poddubnyy D; Protopopov M; Ramiro S; Shea B; Song IH; van Weely S; van der Heijde D
    Semin Arthritis Rheum; 2021 Dec; 51(6):1342-1349. PubMed ID: 34489113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept: in ankylosing spondylitis.
    McCormack PL; Wellington K
    BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D; Calin A; Dougados M; Khan MA; van der Linden S; Bellamy N
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.
    Kiltz U; van der Heijde D; Boonen A; Cieza A; Stucki G; Khan MA; Maksymowych WP; Marzo-Ortega H; Reveille J; Stebbings S; Bostan C; Braun J
    Ann Rheum Dis; 2015 May; 74(5):830-5. PubMed ID: 24399232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
    Davis JC; Van der Heijde DM; Dougados M; Braun J; Cush JJ; Clegg DO; Inman RD; de Vries T; Tsuji WH
    J Rheumatol; 2005 Sep; 32(9):1751-4. PubMed ID: 16142873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New directions in classification and outcome assessment in ankylosing spondylitis.
    van der Heijde D
    Curr Rheumatol Rep; 2004 Apr; 6(2):98-101. PubMed ID: 15016339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.